Canada Clinical Microbiology Market Size & Outlook
Canada clinical microbiology market, 2018-2030 (US$M)
Related Markets
Canada clinical microbiology market highlights
- The Canada clinical microbiology market generated a revenue of USD 168.1 million in 2023 and is expected to reach USD 255.4 million by 2030.
- The Canada market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
- In terms of segment, reagents was the largest revenue generating product in 2023.
- Laboratory Instruments is the most lucrative product segment registering the fastest growth during the forecast period.
Clinical microbiology market data book summary
| Market revenue in 2023 | USD 168.1 million |
| Market revenue in 2030 | USD 255.4 million |
| Growth rate | 6.2% (CAGR from 2023 to 2030) |
| Largest segment | Reagents |
| Fastest growing segment | Laboratory Instruments |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Laboratory Instruments, Automated Culture System, Reagents |
| Key market players worldwide | BioMerieux SA, Abbott Laboratories, BD, Danaher Corp, Hologic Inc, Roche Holding AG ADR, Bruker Corp, Bio-Rad Laboratories Inc |
Other key industry trends
- In terms of revenue, Canada accounted for 3.7% of the global clinical microbiology market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. clinical microbiology market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 255.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Clinical Microbiology Market Scope
Clinical Microbiology Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Canada clinical microbiology market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical microbiology market will help companies and investors design strategic landscapes.
Reagents was the largest segment with a revenue share of 72.22% in 2023. Horizon Databook has segmented the Canada clinical microbiology market based on laboratory instruments, automated culture system, reagents covering the revenue growth of each sub-segment from 2018 to 2030.
Canada is facing the burden of infectious diseases such as respiratory diseases and sexually transmitted infections reaching high levels. As per the data published by Public Health Agency of Canada, an estimated 75,000 people were diagnosed with HIV in 2014, which represents an increase of 9.7% from previous year.
The market will benefit from increased healthcare funding which constitutes 11% of the total GDP. Availability of advanced products and presence of wide network of distribution of international players in Canada is anticipated to boost the growth of the market in Canada.
Reasons to subscribe to Canada clinical microbiology market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Canada clinical microbiology market databook
-
Our clientele includes a mix of clinical microbiology market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada clinical microbiology market , including forecasts for subscribers. This country databook contains high-level insights into Canada clinical microbiology market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Canada clinical microbiology market size, by product, 2018-2030 (US$M)
Canada Clinical Microbiology Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
